Nineteen-year-old Rheanna Laderoute died of sepsis after taking the abortion pill Mifegymiso. This case highlights the deadly risks associated with what is wrongfully portrayed as a safe medical alternative. Laderoute had discovered she was pregnant and went to a women’s health clinic in Brampton, Ontario, where she was given the drug. After the abortion pill, she experienced heavy bleeding and severe abdominal pain for two weeks, then visited the emergency room three times.
On her second visit to the ER, doctors diagnosed Rheanna with peritonitis—a serious swelling of the lining around abdominal organs—as part of a widespread infection. By this point, the infection had progressed to sepsis, which is when the body’s immune response spirals out of control and starts damaging its own tissues. The treatment window was missed, and despite later medical intervention, Laderoute couldn’t be saved.
A Health Canada monograph on Mifegymiso notes that many women experience heavy bleeding, cramps, fever, nausea, vomiting, and other distressing symptoms. While many side effects might resolve, medical literature confirms that some women suffer what are called “severe hemorrhage” or heavy bleeding that requires follow-up surgery. Rheanna’s case tragically illustrates how intense pain and common complications can escalate into life-threatening conditions when alarming symptoms are ignored.
Abortion drugs pose a significant risk to women. The article points out reports that 1-10% of users may experience serious complications. In Rheanna’s case, the delay in recognizing sepsis and treating the infection proved fatal.
Stories like Rheanna’s underline the urgent need to abandon the abortion pill as a dangerous and immoral medical treatment. Laws must be passed that protect women from the dangers of the pill.
Discussion about this post